Table 2

Therapy of the patients at the time of renal biopsy
Therapy Number of patients (percent)
No therapy 29 (50.0)
Diuretics 14 (24.1)
  Frusemide 12 (20.7)
  Frusemide + Spironolactone 1 (1.7)
  Fluitran 1 (1.7)
Steroid 6 (10.3)
ARB 3 (4.4)
ACE 1 (1.7)
ARB + ACE 1 (1.7)
CCB 2 (3.4)
NSAIDs 1(1.7)
Unkown 1(1.7)

ARB, Angiotensin receptor blocker; ACE, Angiotensin converting enzyme inhibitor; CCB, calcium channel blocker; NSAIDs, Non-steroidal anti-rheumatoid drugs.

Kuroda et al.

Kuroda et al. BMC Nephrology 2012 13:118   doi:10.1186/1471-2369-13-118

Open Data